Table 1 Baseline characteristics of the study participants
Triamcinolone acetonide | 10 mg (n = 42) | 40 mg (n = 42) | p-value |
|---|---|---|---|
Age, mean ± SDa | 69.6 ± 9.2 | 69.9 ± 11.3 | 0.9 |
Female, n (%) | 35 (83) | 35 (83) | 1.0 |
Body mass index, mean ± SDa | 24.9 ± 3.5 | 25.4 ± 3.9 | 0.5 |
Comorbidity, n (%) | |||
Hypertension | 25 (60) | 28 (67) | 0.5 |
Diabetics mellitus | 10 (24) | 13 (31) | 0.5 |
Dyslipidemia | 29 (69) | 23 (55) | 0.2 |
Kellgren and Lawrence grade, n (%) | 0.7 | ||
Grade 2 | 11 (26) | 9 (21) | |
Grade 3 | 11 (26) | 15 (36) | |
Grade 4 | 20 (48) | 18 (43) | |
Joint effusion, n (%) | 12 (28) | 15 (36) | 0.4 |